# US 2015/0177254 A1 · Boron-Containing 5-arylidene-3,5-dihydro-4H-imidazol-4-ones

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0177254 A1
- Document ID: US20150177254A1
- Status: Published application
- Kind: A1
- Application number: 14/417,934
- Filed: 2012-08-20
- Published: 2015-06-25
- Earliest claimed: 2012-08-20
- Assignees: Evrogen Joint Stock Company
- Inventors: Ilia Victorovich Yampolsky; Konstantin Anatolyevich Lukyanov; Mikhail Sergeyevich Baranov
- Web page: https://patentgrep.com/patent/US20150177254A1

## CPC

- C07F 5/027: {Organoboranes and organoborohydrides}
- C07F 5/02: Boron compounds
- G01N 33/582: {with fluorescent label}
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Novel compounds of the general formula are introduced, containing 5-arylidene-3,5-dihydro-4h-imidazol-4-one core. These compounds can be used for fluorescent staining of cell membranes, biomolecules' labeling in vivo and in vitro, a number of compounds also have photoacidic properties. This allows to use them, for example, as instruments to drastically change pH of a medium, and also as dynamic fluorescent probes for investigation of complex objects like proteins and micellae, as well as in studies of hydration dynamics and in photolithography.

## Claims

### Claim 1

Compound of the formula (I):
where
A is selected from H, linear or branched C1-6 alkyl or C4-6 cycloalkyl,
D is selected from double or triple bond, aryl, heteroaryl, or may be absent,
X is selected from hydrogen, halogen, unsubstituted or C1-6 alkyl substituted aminogroup, in which substituents not necessarily form cyclic substituted pyrrol or pyrrolidine derivatives, or C4-6 cycloalkyl substituted aminogroup, azide, isothiocyanate, isocyanate, alchohol or thiol group, acethylene fragment, carboxyl group, or may be absent,
Y is independently selected from fluorine, hydroxyl or alkoxyl group with C1-6 alkyl substituent,
R1, R2, R3, R4 are independently selected from hydrogen, halogen, unsubstituted or C1-6 alkyl substituted aminogroup, in which substituents not necessarily form cyclic substituted pyrrol or pyrrolidine derivatives, or C4-6 cycloalkyl substituted aminogroup, hydroxyl or C1-6 alkyl alkoxyl group,
and also it's salts and/or stereoisomers and/or their conjugates.

### Claim 2 (depends on 1)

Compound according to claim 1, which is fluorescent.

### Claim 3 (depends on 2)

Compound according to claim 2 for labeling of biomolecules or staining of cell membranes.

### Claim 4 (depends on 3)

Compound according to claim 3, which is (Z)-4-(2-difluoroboryl)-4-hydroxybenzylidene)-1,2-dimethyl-1H-imidazole-5(4H)-one, for biomolecules' labeling.

### Claim 5 (depends on 3)

Compound according to claim 3, which is (Z)-4-(4-(diethylamino)-2-(difluoroboryl)benzylidene)-1,2-dimethyl-1H-imidazole-5(4H)-one, for staining of cell membranes.

### Claim 6 (depends on 2)

Compound according to claim 2, in which R2 is OH, showing photoacidic properties.

### Claim 7 (depends on 6)

Compound according to claim 6, which is (Z)-4-(2-difluoroboryl)-3,5-difluoro-4-hydroxybenzylidene)-1,2-dimethyl-1H-imidazole-5(4H)-one.
